Actinoplanes utahensis ZJB-08196 fed-batch fermentation at elevated osmolality for enhancing acarbose production

Bioresour Technol. 2012 Jan;103(1):337-42. doi: 10.1016/j.biortech.2011.09.121. Epub 2011 Oct 8.

Abstract

Acarbose, a potent α-glucosidase inhibitor, is as an oral anti-diabetic drug for treatment of the type two, noninsulin-dependent diabetes. Actinoplanes utahensis ZJB-08196, an osmosis-resistant actinomycete, had a broad osmolality optimum between 309 mOsm kg(-1) and 719 mOsm kg(-1). Utilizing this unique feature, an fed-batch culture process under preferential osmolality was constructed through intermittently feeding broths with feed medium consisting of 14.0 g l(-1) maltose, 6.0 g l(-1) glucose and 9.0 g l(-1) soybean meal, at 48 h, 72 h, 96 h and 120 h. This intermittent fed-batch culture produced a peak acarbose titer of 4878 mg l(-1), increased by 15.9% over the batch culture.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acarbose / metabolism*
  • Batch Cell Culture Techniques / methods*
  • Biomass
  • Culture Media / pharmacology
  • Fermentation / drug effects
  • Fermentation / physiology*
  • Glucose / pharmacology
  • Maltose / pharmacology
  • Micromonosporaceae / drug effects
  • Micromonosporaceae / growth & development
  • Micromonosporaceae / physiology*
  • Osmolar Concentration
  • Sodium Glutamate / pharmacology
  • Time Factors

Substances

  • Culture Media
  • Maltose
  • Glucose
  • Acarbose
  • Sodium Glutamate